Tech Company Financing Transactions
Carcinotech Funding Round
Eos Advisory, Alba Equity and Gabriel Investments invested in a $5.4 million funding round for Carcinotech. The round was announced on 1/29/2024.
Transaction Overview
Company Name
Announced On
1/29/2024
Transaction Type
Venture Equity
Amount
$5,350,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
Roslin Innovation Centre, Easter Bush Campus
Edinburgh, EH25 9RG
UK
Edinburgh, EH25 9RG
UK
Phone
Undisclosed
Website
Email Address
Overview
Carcinotech is a MedTech company with expertise in manufacturing 3D printed living tumours using patient-derived biopsies, primary cells, immune cells and cancer stem cells. Carcinotech's advanced models provide a platform for rapid, ethical, and accurate drug screening, pre-clinical and personalised medicine testing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Albert Nicholl
Chief Executive Officer
Ishani Malhotra
Chief Financial Officer
Lorna Peers
Chief Operating Officer
Liam McFarlane
VP - Bus. Development
Kieran Casey
Browse more venture capital transactions:
Prev: 1/29/2024: Yume Food Australia venture capital transaction
Next: 1/29/2024: Coxwave venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs